Bivalent is better. Simple is better,” one FDA committee member said about vaccines that tackle the original strains of COVID ...

The FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid vaccine going forward ...

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The U.S. Food and Drug Administration's vaccine advisory panel on Thursday voted unanimously to recommend that the agency ...

Protecting against Covid infection with the current mRNA technology is unrealistic, a vaccine expert said in a paper ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

Moderna and the Food and Drug Association (FDA) have been accused of concealing data during the approval process for the pharma giant's bivalent Covid booster. Vaccine advisors who signed off on ...